Chelsea's Women's Champions League campaign is a tale of two contrasting performances. On one hand, their defense has been exceptional, with the team maintaining a perfect record in Europe and extending their clean-sheet streak to six matches, the longest in the club's competition history. However, their inability to score freely has raised concerns about their ability to compete with the continent's best teams. Despite being unbeaten in the league and Champions League, Chelsea's attacking play has lacked the cutting edge needed to turn promising opportunities into convincing victories. They have scored just four goals in five Women's Champions League matches, with their most convincing scoreline being a 2-0 victory over AS Roma. The team's reliance on defensive strength alone may not be enough to compensate for their lack of clinical finishing, especially in the knockout stages. The absence of key players, including Melvine Malard and Manaka Matsukubo, has contributed to Chelsea's attacking woes. Mayra Ramírez's prolonged absence has also left a significant hole in the team, with greater responsibility falling on Aggie Beever-Jones. However, Beever-Jones has struggled to rediscover her best form, with a lack of confidence evident in her performances. Chelsea's European campaign has been marked by missed opportunities, with the team creating chances but failing to convert them. Against BK Häcken, they had 15 attempts on goal but were unable to break the deadlock. The team's ability to grind out results without necessarily playing at their best is a testament to their resilience, but it may not be enough to win the competition. While Chelsea remain in a strong position, their defensive brilliance may only take them so far. The Champions League is ultimately won by the teams that take their opportunities when it matters most. Unless Chelsea rediscover their clinical edge, their chances of winning the competition may be hindered by their struggles to score goals.